Publication date: October 2026 Source: Research and Practice in Thrombosis and Haemostasis, Volume 10, Issue 7 Author(s): Parwana Hussaini, Trine-Lise Larsen, Waleed Ghanima, Anders Erik Astrup Dahm
Clinical significance of symptomatic and incidental venous thromboembolism in patients with cancer treated with apixaban. // Research and Practice in Thrombosis and Haemostasis. – URL: https://www.sciencedirect.com/science/article/pii/S2475037926036265?dgcid=rss_sd_all
Clinical significance of symptomatic and incidental venous thromboembolism in patients with cancer treated with apixaban. Research and Practice in Thrombosis and Haemostasis. https://www.sciencedirect.com/science/article/pii/S2475037926036265?dgcid=rss_sd_all
“Clinical significance of symptomatic and incidental venous thromboembolism in patients with cancer treated with apixaban.” Research and Practice in Thrombosis and Haemostasis.
@article{article119477,
title = {Clinical significance of symptomatic and incidental venous thromboembolism in patients with cancer treated with apixaban},
journal = {Research and Practice in Thrombosis and Haemostasis},
url = {https://www.sciencedirect.com/science/article/pii/S2475037926036265?dgcid=rss_sd_all}
}